HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

3,6-di-O-acetyl-2-deoxy-D-glucopyranose

Also Known As:

((2R,3S,4R)-4-acetyloxy-3,6-dihydroxyoxan-2-yl)methyl acetate; 3,6-di-O-acetyl-2-deoxy-D-glucose; WP-1122; WP1122

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Carbohydrates: 22023
- Deoxy Sugars: 6
  - Deoxyglucose: 2901
    - 3,6-di-O-acetyl-2-deoxy-D-glucopyranose: 1

Experts

1.	Bankson, James A: 1 article (10/2019)
2.	Le Roux, Lucia: 1 article (10/2019)
3.	Michel, Keith A: 1 article (10/2019)
4.	Priebe, Waldemar: 1 article (10/2019)
5.	Schellingerhout, Dawid: 1 article (10/2019)
6.	Walker, Christopher M: 1 article (10/2019)
7.	Zieliński, Rafal: 1 article (10/2019)

Related Diseases

1.

Glioma (Gliomas)

10/01/2019 - "After treatment with WP1122, a decrease in lactate was observed in mice with glioma (baseline and treatment mean kPL, 0.027 and 0.018 sec-1, respectively, P = .01; baseline and posttreatment mean nLac, 0.28 and 0.22, respectively, P = .01) whereas no significant decrease was observed in healthy control mice (baseline and posttreatment mean kPL, 0.011 and 0.017 sec-1, respectively, P = .91; baseline and posttreatment mean nLac, 0.16 and 0.21, respectively, P = .84).ConclusionHyperpolarized carbon 13 measurements of pyruvate metabolism can provide rapid feedback for monitoring treatment response in glioma.© RSNA, 2019."

Related Drugs and Biologics

1.	Lactic Acid (Lactate)
2.	Pyruvic Acid (Pyruvate)
3.	Carbon

Related Therapies and Procedures

1.	Aftercare (After-Treatment)